5-Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan as a Potential Standard for Second-line Therapy in Extrapulmonary Neuroendocrine Carcinomas

Background: Neuroendocrine carcinomas (NECs) are classified by the World Health Organization as poorly differentiated, aggressive Grade 3 tumors with high proliferative indices and frequent lung involvement. While initial treatment for advanced NEC typically involves etoposide and platinum-based the...

Full description

Bibliographic Details

Published in:	Journal of Cancer Research and Practice
Main Authors:	I-Wei Ho, Nai-Jung Chiang, Jiun-I Lai, Peter Mu-Hsin Chang, San-Chi Chen, Yi-Ping Hung, Ming-Huang Chen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-12-01
Subjects:	extrapulmonary 5-fluorouracil leucovorin and irinotecan oxaliplatin second-line therapy ipilimumab neuroendocrine carcinoma neuroendocrine carcinomas nivolumab
Online Access:	https://journals.lww.com/10.4103/ejcrp.eJCRP-D-24-00032